Research

We deliver translational solutions that start from specific clinical needs identified by our clinical partners, leveraging novel technological approaches to accelerate implementation into the clinic with dramatically reduced lead times. We revolutionize precision medicine through our state-of-the-art in-house antibody facility and advanced bioinformatics and AI capabilities.

Our research spans three cutting-edge areas: 

• immuno-oncology that harnesses the immune system's power against cancer,
• early diagnostics and surveillance technologies, and
• mental health research to optimize patient adaptation and quality of life. 

Immuno-oncology

Immuno-oncology has provided several exciting clinical improvements by focusing on how the immune system regulates tumour eradication. Discovery and functional implementation of novel target molecules that regulate an effective tumour response will provide cancer patients with new treatment options and, consequently, better clinical outcomes.

Precision Diagnostics

Since we cannot treat what we cannot measure, advanced diagnostics go hand in hand with precision immune-oncology. Developing precision diagnostics allows us to find and define malignant tumours earlier, predict the best treatment choice, and monitor treatment success, altogether resulting in improved survival.

Mental health in cancer

Cancer is a life-threatening disease that can cause severe trauma, disrupting the balance in a person's life, and mental health challenges are common in cancer patients. Interestingly, patients differ in processing and adapting to their diagnosis and treatment, independent of cancer severity. We aim to elucidate the biological markers behind susceptibility and resilience to mental health conditions in cancer, how they interact with quality of life and socioeconomic factors, and to characterise their potential as druggable targets.